Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00512798
Status:
TERMINATED
Last Update Posted:
2012-10-02
First Post:
2007-08-06
Brief Title:
Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma
Sponsor:
Organization:
Vanderbilt-Ingram Cancer Center